Aasen thomas h - direct investment history in Acadia pharmaceuticals inc

Filed on 2014-04-04 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-14-001112.txt Sec File: edgar/data/1070494/0001415889-14-001112-index.htm

2014-04-04 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 7500 shares at $0 remaining shares owned 82971

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 1.55 has valueitem expiration due date 2020-03-11 underlying security shares 7500 underlying security title Common Stock

f3 25% of the shares subject to the stock option vested and became exercisable on march 12, 2011. the remaining shares vested and became exercisable thereafter in 36 equal monthly installments.


Filed on 2014-04-04 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-14-001112.txt Sec File: edgar/data/1070494/0001415889-14-001112-index.htm

2014-04-04 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 15000 shares at $22.484 remaining shares owned 0

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person in 2013.
f2 the price reported in column 4 is a weighted-average price. these shares were sold in multiple transactions at prices ranging from $21.45 to $23.00 per share, inclusive. the reporting person undertakes to provide acadia pharmaceuticals inc., any security holder of acadia pharmaceuticals inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.


Filed on 2014-04-04 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-14-001112.txt Sec File: edgar/data/1070494/0001415889-14-001112-index.htm

2014-04-04 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 15000 shares at $0 remaining shares owned 15000

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2014-04-04 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-14-001112.txt Sec File: edgar/data/1070494/0001415889-14-001112-index.htm

2014-04-04 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 15000 shares at $0 remaining shares owned 23848

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2014-04-04 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-14-001112.txt Sec File: edgar/data/1070494/0001415889-14-001112-index.htm

2014-04-04 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 7500 shares at $1.55 remaining shares owned 38848

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2014-01-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-14-000033.txt Sec File: edgar/data/1070494/0001415889-14-000033-index.htm

2014-01-02 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 22000 shares at $0 remaining shares owned 90471

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 1.55 has valueitem expiration due date 2020-03-11 underlying security shares 22000 underlying security title Common Stock

f3 25% of the shares subject to the stock option vested and became exercisable on march 12, 2011. the remaining shares vest and become exercisable thereafter in 36 equal monthly installments.


Filed on 2014-01-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-14-000033.txt Sec File: edgar/data/1070494/0001415889-14-000033-index.htm

2014-01-02 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 30000 shares at $24.8778 remaining shares owned 0

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person in 2012.
f2 the price reported in column 4 is a weighted-average price. these shares were sold in multiple transactions at prices ranging from $24.50 to $25.01 per share, inclusive. the reporting person undertakes to provide acadia pharmaceuticals inc., any security holder of acadia pharmaceuticals inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.


Filed on 2014-01-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-14-000033.txt Sec File: edgar/data/1070494/0001415889-14-000033-index.htm

2014-01-02 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 30000 shares at $0 remaining shares owned 30000

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2014-01-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-14-000033.txt Sec File: edgar/data/1070494/0001415889-14-000033-index.htm

2014-01-02 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 30000 shares at $0 remaining shares owned 31348

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2014-01-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-14-000033.txt Sec File: edgar/data/1070494/0001415889-14-000033-index.htm

2014-01-02 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 22000 shares at $1.55 remaining shares owned 61348

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2013-12-16 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-002575.txt Sec File: edgar/data/1070494/0001415889-13-002575-index.htm

2013-12-12 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 1000 shares at $0 remaining shares owned 25000

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 6.95 has valueitem expiration due date 2015-03-10 underlying security shares 1000 underlying security title Common Stock

f4 25% of the shares subject to the stock option vested and became exercisable on march 11, 2006. the remaining shares vested and became exercisable thereafter in 36 equal monthly installments.


Filed on 2013-12-16 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-002575.txt Sec File: edgar/data/1070494/0001415889-13-002575-index.htm

2013-12-12 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 11000 shares at $0 remaining shares owned 112471

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 1.55 has valueitem expiration due date 2020-03-11 underlying security shares 11000 underlying security title Common Stock

f3 25% of the shares subject to the stock option vested and became exercisable on march 12, 2011. the remaining shares vest and become exercisable thereafter in 36 equal monthly installments.


Filed on 2013-12-16 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-002575.txt Sec File: edgar/data/1070494/0001415889-13-002575-index.htm

2013-12-12 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 1000 shares at $6.95 remaining shares owned 39348

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2013-12-16 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-002575.txt Sec File: edgar/data/1070494/0001415889-13-002575-index.htm

2013-12-12 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 11000 shares at $1.55 remaining shares owned 38348

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2013-12-16 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-002575.txt Sec File: edgar/data/1070494/0001415889-13-002575-index.htm

2013-12-02 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 2000 shares at $0 remaining shares owned 27348

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses

f1 this disposition reflects a charitable gift made by the reporting person.
f2 includes 5,263 shares acquired on november 29, 2013 by mr. aasen under the acadia pharmaceuticals employee stock purchase plan.


Filed on 2013-10-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001969.txt Sec File: edgar/data/1070494/0001415889-13-001969-index.htm

2013-10-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 17500 shares at $0 remaining shares owned 123471

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 1.55 has valueitem expiration due date 2020-03-11 underlying security shares 17500 underlying security title Common Stock

f4 25% of the shares subject to the stock option vested and became exercisable on march 12, 2011. the remaining shares vest and become exercisable thereafter in 36 equal monthly installments.


Filed on 2013-10-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001969.txt Sec File: edgar/data/1070494/0001415889-13-001969-index.htm

2013-10-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 5000 shares at $0 remaining shares owned 26000

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 6.95 has valueitem expiration due date 2015-03-10 underlying security shares 5000 underlying security title Common Stock

f3 25% of the shares subject to the stock option vested and became exercisable on march 11, 2006. the remaining shares vested and became exercisable thereafter in 36 equal monthly installments.


Filed on 2013-10-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001969.txt Sec File: edgar/data/1070494/0001415889-13-001969-index.htm

2013-10-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 30000 shares at $27.8707 remaining shares owned 0

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person in 2012.
f2 the price reported in column 4 is a weighted-average price. these shares were sold in multiple transactions at prices ranging from $27.75 to $28.00 per share, inclusive. the reporting person undertakes to provide acadia pharmaceuticals inc., any security holder of acadia pharmaceuticals inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.


Filed on 2013-10-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001969.txt Sec File: edgar/data/1070494/0001415889-13-001969-index.htm

2013-10-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 30000 shares at $0 remaining shares owned 30000

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2013-10-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001969.txt Sec File: edgar/data/1070494/0001415889-13-001969-index.htm

2013-10-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 30000 shares at $0 remaining shares owned 24085

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2013-10-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001969.txt Sec File: edgar/data/1070494/0001415889-13-001969-index.htm

2013-10-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 17500 shares at $1.55 remaining shares owned 54085

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2013-10-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001969.txt Sec File: edgar/data/1070494/0001415889-13-001969-index.htm

2013-10-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 5000 shares at $6.95 remaining shares owned 36585

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2013-08-15 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001643.txt Sec File: edgar/data/1070494/0001415889-13-001643-index.htm

2013-08-13 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 15000 shares at $0 remaining shares owned 58708

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise date 2011-03-12 exercise price 1.55 has valueitem expiration due date 2020-03-11 underlying security shares 15000 underlying security title Common Stock


Filed on 2013-08-15 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001643.txt Sec File: edgar/data/1070494/0001415889-13-001643-index.htm

2013-08-13 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 30000 shares at $0 remaining shares owned 82263

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise date 2011-03-12 exercise price 1.55 has valueitem expiration due date 2020-03-11 underlying security shares 30000 underlying security title Common Stock


Filed on 2013-08-15 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001643.txt Sec File: edgar/data/1070494/0001415889-13-001643-index.htm

2013-08-13 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 60000 shares at $20.153 remaining shares owned 0

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f2 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person in 2012.
f3 the price reported in column 4 is a weighted-average price. these shares were sold in multiple transactions at prices ranging from $19.80 to $20.43 per share, inclusive. the reporting person undertakes to provide acadia pharmaceuticals inc., any security holder of acadia pharmaceuticals inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.


Filed on 2013-08-15 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001643.txt Sec File: edgar/data/1070494/0001415889-13-001643-index.htm

2013-08-13 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 60000 shares at $0 remaining shares owned 60000

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2013-08-15 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001643.txt Sec File: edgar/data/1070494/0001415889-13-001643-index.htm

2013-08-13 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 60000 shares at $0 remaining shares owned 31585

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2013-08-15 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001643.txt Sec File: edgar/data/1070494/0001415889-13-001643-index.htm

2013-08-13 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 15000 shares at $1.55 remaining shares owned 91585

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2013-08-15 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001643.txt Sec File: edgar/data/1070494/0001415889-13-001643-index.htm

2013-08-13 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 30000 shares at $1.55 remaining shares owned 76585

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security

f1 includes 2,085 shares acquired on may 31, 2013 by mr. aasen under the acadia pharmaceuticals employee stock purchase plan.


Filed on 2013-06-11 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-001167.txt Sec File: edgar/data/1070494/0001415889-13-001167-index.htm

2013-06-07 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 175000 shares at $0 remaining shares owned 175000

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 17.01 has valueitem expiration due date 2023-06-06 underlying security shares 175000 underlying security title Common Stock

f1 25% of the shares subject to the stock option vest and become exercisable on june 7, 2014. the remaining shares vest and become exercisable thereafter in 36 equal monthly installments.


Filed on 2013-04-12 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000739.txt Sec File: edgar/data/1070494/0001415889-13-000739-index.htm

2013-04-11 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 14029 shares at $0 remaining shares owned 73708

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise date 2011-03-12 exercise price 1.55 has valueitem expiration due date 2020-03-11 underlying security shares 14029 underlying security title Common Stock


Filed on 2013-04-12 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000739.txt Sec File: edgar/data/1070494/0001415889-13-000739-index.htm

2013-04-11 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 12500 shares at $0 remaining shares owned 0

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 2 has valueitem expiration due date 2014-03-11 underlying security shares 12500 underlying security title Common Stock

f2 immediately.


Filed on 2013-04-12 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000739.txt Sec File: edgar/data/1070494/0001415889-13-000739-index.htm

2013-04-11 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 7500 shares at $0 remaining shares owned 0

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 1.08 has valueitem expiration due date 2013-09-07 underlying security shares 7500 underlying security title Common Stock

f2 immediately.


Filed on 2013-04-12 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000739.txt Sec File: edgar/data/1070494/0001415889-13-000739-index.htm

2013-04-11 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 40000 shares at $11.06 remaining shares owned 0

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person in 2011.


Filed on 2013-04-12 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000739.txt Sec File: edgar/data/1070494/0001415889-13-000739-index.htm

2013-04-11 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 40000 shares at $0 remaining shares owned 40000

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2013-04-12 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000739.txt Sec File: edgar/data/1070494/0001415889-13-000739-index.htm

2013-04-11 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 40000 shares at $0 remaining shares owned 44500

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2013-04-12 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000739.txt Sec File: edgar/data/1070494/0001415889-13-000739-index.htm

2013-04-11 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 14029 shares at $1.55 remaining shares owned 84500

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2013-04-12 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000739.txt Sec File: edgar/data/1070494/0001415889-13-000739-index.htm

2013-04-11 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 12500 shares at $2 remaining shares owned 70471

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2013-04-12 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000739.txt Sec File: edgar/data/1070494/0001415889-13-000739-index.htm

2013-04-11 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 7500 shares at $1.08 remaining shares owned 57971

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2013-04-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000632.txt Sec File: edgar/data/1070494/0001415889-13-000632-index.htm

2013-04-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 36490 shares at $0 remaining shares owned 7500

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 1.08 has valueitem expiration due date 2013-09-07 underlying security shares 36490 underlying security title Common Stock

f3 immediately.


Filed on 2013-04-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000632.txt Sec File: edgar/data/1070494/0001415889-13-000632-index.htm

2013-04-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 3510 shares at $0 remaining shares owned 0

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 1.08 has valueitem expiration due date 2013-09-07 underlying security shares 3510 underlying security title Common Stock

f3 immediately.


Filed on 2013-04-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000632.txt Sec File: edgar/data/1070494/0001415889-13-000632-index.htm

2013-04-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 40000 shares at $7.6771 remaining shares owned 0

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person in 2011.
f2 the price reported in column 4 is a weighted-average price. these shares were sold in multiple transactions at prices ranging from $7.59 to $7.90 per share, inclusive. the reporting person undertakes to provide acadia pharmaceuticals inc., any security holder of acadia pharmaceuticals inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.


Filed on 2013-04-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000632.txt Sec File: edgar/data/1070494/0001415889-13-000632-index.htm

2013-04-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 40000 shares at $0 remaining shares owned 40000

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2013-04-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000632.txt Sec File: edgar/data/1070494/0001415889-13-000632-index.htm

2013-04-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 40000 shares at $0 remaining shares owned 50471

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2013-04-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000632.txt Sec File: edgar/data/1070494/0001415889-13-000632-index.htm

2013-04-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 36490 shares at $1.08 remaining shares owned 90471

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2013-04-03 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000632.txt Sec File: edgar/data/1070494/0001415889-13-000632-index.htm

2013-04-01 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 3510 shares at $1.08 remaining shares owned 53981

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2013-01-18 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000092.txt Sec File: edgar/data/1070494/0001415889-13-000092-index.htm

2013-01-17 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 12000 shares at $0 remaining shares owned 43990

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 1.08 has valueitem expiration due date 2013-09-07 underlying security shares 12000 underlying security title Common Stock

f2 immediately.


Filed on 2013-01-18 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-13-000092.txt Sec File: edgar/data/1070494/0001415889-13-000092-index.htm

2013-01-17 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 12000 shares at $1.08 remaining shares owned 50471

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security

f1 includes 10,000 shares acquired on november 30, 2012 by mr. aasen under the acadia pharmaceuticals employee stock purchase plan.


Filed on 2012-11-29 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001792.txt Sec File: edgar/data/1070494/0001415889-12-001792-index.htm

2012-11-28 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 5000 shares at $0 remaining shares owned 3510

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise date 2003-09-08 exercise price 1.08 has valueitem expiration due date 2013-09-07 underlying security shares 5000 underlying security title Common Stock


Filed on 2012-11-29 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001792.txt Sec File: edgar/data/1070494/0001415889-12-001792-index.htm

2012-11-28 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 9100 shares at $5.2499 remaining shares owned 0

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person in 2011.
f3 the price reported in column 4 is a weighted-average price. these shares were sold in multiple transactions at prices ranging from $5.24 to $5.26 per share, inclusive.


Filed on 2012-11-29 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001792.txt Sec File: edgar/data/1070494/0001415889-12-001792-index.htm

2012-11-28 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 5000 shares at $0 remaining shares owned 9100

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2012-11-29 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001792.txt Sec File: edgar/data/1070494/0001415889-12-001792-index.htm

2012-11-28 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 5000 shares at $0 remaining shares owned 28471

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2012-11-29 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001792.txt Sec File: edgar/data/1070494/0001415889-12-001792-index.htm

2012-11-28 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 5000 shares at $1.08 remaining shares owned 33471

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2012-11-29 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001792.txt Sec File: edgar/data/1070494/0001415889-12-001792-index.htm

2012-11-27 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 30900 shares at $6.2414 remaining shares owned 4100

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person in 2011.
f2 the price reported in column 4 is a weighted-average price. these shares were sold in mulitple transactions at prices ranging from $6.00 to $6.50 per share, inclusive. the reporting person undertakes to provide acadia pharmaceuticals inc., any security holder of acadia pharmaceuticals inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this form 4.


Filed on 2012-11-29 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001792.txt Sec File: edgar/data/1070494/0001415889-12-001792-index.htm

2012-11-27 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 33631 shares at $0 remaining shares owned 35000

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2012-11-29 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001792.txt Sec File: edgar/data/1070494/0001415889-12-001792-index.htm

2012-11-27 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 33631 shares at $0 remaining shares owned 28471

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2012-09-11 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001365.txt Sec File: edgar/data/1070494/0001415889-12-001365-index.htm

2012-09-07 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 7500 shares at $0.00 remaining shares owned 20000

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise date 2003-09-09 exercise price 1.50 has valueitem expiration due date 2012-09-08 underlying security shares 7500 underlying security title Common Stock


Filed on 2012-09-11 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001365.txt Sec File: edgar/data/1070494/0001415889-12-001365-index.htm

2012-09-07 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 7500 shares at $1.50 remaining shares owned 62102

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2012-09-11 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001365.txt Sec File: edgar/data/1070494/0001415889-12-001365-index.htm

2012-09-07 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc remaining shares owned 1369

Common Stock Acadia Pharmaceuticals Inc Acad


Filed on 2012-08-06 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001138.txt Sec File: edgar/data/1070494/0001415889-12-001138-index.htm

2012-08-03 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc sold 5000 shares at $0.00 remaining shares owned 27500

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise date 2003-09-09 exercise price 1.50 has valueitem expiration due date 2012-09-08 underlying security shares 5000 underlying security title Common Stock


Filed on 2012-08-06 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001138.txt Sec File: edgar/data/1070494/0001415889-12-001138-index.htm

2012-08-03 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 5000 shares at $1.50 remaining shares owned 54602

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security

f1 includes an aggregate of 39,936 shares acquired by mr. aasen under the acadia pharmaceuticals employee stock puchase plan since inception.
f2 number reflects 965 shares gifted by the aasen family trust on december 18, 2007, but incorrectly attributed to direct holdings of mr. aasen.


Filed on 2012-08-06 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-001138.txt Sec File: edgar/data/1070494/0001415889-12-001138-index.htm

2012-08-03 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc remaining shares owned 1369

Common Stock Acadia Pharmaceuticals Inc Acad

f2 number reflects 965 shares gifted by the aasen family trust on december 18, 2007, but incorrectly attributed to direct holdings of mr. aasen.


Filed on 2012-03-26 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4/a

Accession 0001415889-12-000432.txt Sec File: edgar/data/1070494/0001415889-12-000432-index.htm

2012-03-23 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 175000 shares at $0.00 remaining shares owned 175000

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 2.18 has valueitem expiration due date 2022-03-22 underlying security shares 175000 underlying security title Common Stock

f1 price was incorretly listed at $1.18 originally.
f2 25% of the shares subject to the stock option vest and become exercisable on march 23, 2013. the remaining shares vest and become exercisable thereafter in 36 equal monthly installments.


Filed on 2012-03-26 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001415889-12-000424.txt Sec File: edgar/data/1070494/0001415889-12-000424-index.htm

2012-03-23 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo And Cbo)

Invested in Acadia Pharmaceuticals Inc bought 175000 shares at $0.00 remaining shares owned 175000

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 1.18 has valueitem expiration due date 2022-03-22 underlying security shares 175000 underlying security title Common Stock

f1 25% of the shares subject to the stock option vest and become exercisable on march 23, 2013. the remaining shares vest and become exercisable thereafter in 36 equal monthly installments.


Filed on 2011-03-29 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-11-020613.txt Sec File: edgar/data/1070494/0001181431-11-020613-index.htm

2011-03-25 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo Cbo)

Invested in Acadia Pharmaceuticals Inc bought 175000 shares at $0 remaining shares owned 175000

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 1.62 has valueitem expiration due date 2021-03-24 underlying security shares 175000 underlying security title Common Stock

f1 25% of the shares subject to the stock option vest and become exercisable on march 25, 2012. the remaining shares vest and become exercisable thereafter in 36 equal monthly installments.


Filed on 2010-03-16 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-10-016675.txt Sec File: edgar/data/1070494/0001181431-10-016675-index.htm

2010-03-12 Aasen Thomas H (CIK 1291969) through Direct (Exec Vp Cfo Cbo)

Invested in Acadia Pharmaceuticals Inc bought 200000 shares at $0 remaining shares owned 200000

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 1.55 has valueitem expiration due date 2020-03-11 underlying security shares 200000 underlying security title Common Stock

f1 25% of the shares subject to the stock option vest and become exercisable on march 12, 2011. the remaining shares vest and become exercisable thereafter in 36 equal monthly installments.


Filed on 2008-10-22 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-08-058072.txt Sec File: edgar/data/1070494/0001181431-08-058072-index.htm

2008-10-20 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc bought 50000 shares at $0 remaining shares owned 50000

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 2 has valueitem expiration due date 2018-10-19 underlying security shares 50000 underlying security title Common Stock

f1 50% of the shares subject to the stock option vest and become exercisable on october 20, 2010. the remaining shares vest and become exercisable thereafter in 24 equal monthly installments.


Filed on 2008-03-11 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-08-017988.txt Sec File: edgar/data/1070494/0001181431-08-017988-index.htm

2008-03-07 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc bought 26000 shares at $0 remaining shares owned 26000

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 8.32 has valueitem expiration due date 2018-03-06 underlying security shares 26000 underlying security title Common Stock

f1 25% of the shares subject to the stock option vest and become exercisable on march 7, 2009. the remaining shares vest and become exercisable thereafter in 36 equal monthly installments.


Filed on 2008-02-14 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-08-010653.txt Sec File: edgar/data/1070494/0001181431-08-010653-index.htm

2008-02-14 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 5000 shares at $0 remaining shares owned 55990

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise date 2003-09-08 exercise price 1.08 has valueitem expiration due date 2013-09-07 underlying security shares 5000 underlying security title Common Stock

f4 the 4,000 shares exercised on december 6, 2007 were incorrectly attributed to this option (an iso), but actually came from the other option (an nso) of the same date and terms.


Filed on 2008-02-14 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-08-010653.txt Sec File: edgar/data/1070494/0001181431-08-010653-index.htm

2008-02-13 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 8000 shares at $0 remaining shares owned 8510

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise date 2003-09-08 exercise price 1.08 has valueitem expiration due date 2013-09-07 underlying security shares 8000 underlying security title Common Stock

f3 the 4000 shares exercised on december 6, 2007 were from this option (an nso), but were attributed to the other option (an iso) of the same date and terms.


Filed on 2008-02-14 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-08-010653.txt Sec File: edgar/data/1070494/0001181431-08-010653-index.htm

2008-02-14 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc bought 5000 shares at $1.08 remaining shares owned 13899

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2008-02-14 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-08-010653.txt Sec File: edgar/data/1070494/0001181431-08-010653-index.htm

2008-02-13 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 2000 shares at $10.94 remaining shares owned 2334

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f2 these transactions were effected pursuant to a previously established sales plan under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for non-dsicretionary sales (and corresponding exercises of options, if applicable) pursuant to predetermined trading parameters that do no permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan.


Filed on 2008-02-14 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-08-010653.txt Sec File: edgar/data/1070494/0001181431-08-010653-index.htm

2008-02-13 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 2000 shares at $10.9 remaining shares owned 4334

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f2 these transactions were effected pursuant to a previously established sales plan under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for non-dsicretionary sales (and corresponding exercises of options, if applicable) pursuant to predetermined trading parameters that do no permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan.


Filed on 2008-02-14 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-08-010653.txt Sec File: edgar/data/1070494/0001181431-08-010653-index.htm

2008-02-13 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 4000 shares at $10.75 remaining shares owned 6334

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f2 these transactions were effected pursuant to a previously established sales plan under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for non-dsicretionary sales (and corresponding exercises of options, if applicable) pursuant to predetermined trading parameters that do no permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan.


Filed on 2008-02-14 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-08-010653.txt Sec File: edgar/data/1070494/0001181431-08-010653-index.htm

2008-02-13 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc bought 8000 shares at $0 remaining shares owned 10334

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses

f2 these transactions were effected pursuant to a previously established sales plan under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for non-dsicretionary sales (and corresponding exercises of options, if applicable) pursuant to predetermined trading parameters that do no permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan.


Filed on 2008-02-14 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-08-010653.txt Sec File: edgar/data/1070494/0001181431-08-010653-index.htm

2008-02-13 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 8000 shares at $0 remaining shares owned 8899

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses

f2 these transactions were effected pursuant to a previously established sales plan under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for non-dsicretionary sales (and corresponding exercises of options, if applicable) pursuant to predetermined trading parameters that do no permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan.


Filed on 2008-02-14 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-08-010653.txt Sec File: edgar/data/1070494/0001181431-08-010653-index.htm

2008-02-13 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc bought 8000 shares at $1.08 remaining shares owned 16899

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security

f2 these transactions were effected pursuant to a previously established sales plan under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for non-dsicretionary sales (and corresponding exercises of options, if applicable) pursuant to predetermined trading parameters that do no permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan.


Filed on 2008-02-14 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-08-010653.txt Sec File: edgar/data/1070494/0001181431-08-010653-index.htm

2007-12-18 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 965 shares at $0 remaining shares owned 8899

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses

f1 this disposition reflects a charitable gift made by mr. aasen.


Filed on 2007-12-07 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-074148.txt Sec File: edgar/data/1070494/0001181431-07-074148-index.htm

2007-12-07 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 2000 shares at $0 remaining shares owned 56990

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise date 2003-09-08 exercise price 1.08 has valueitem expiration due date 2013-09-07 underlying security shares 2000 underlying security title Common Stock


Filed on 2007-12-07 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-074148.txt Sec File: edgar/data/1070494/0001181431-07-074148-index.htm

2007-12-06 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 4000 shares at $0 remaining shares owned 58990

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise date 2003-09-08 exercise price 1.08 has valueitem expiration due date 2013-09-07 underlying security shares 4000 underlying security title Common Stock


Filed on 2007-12-07 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-074148.txt Sec File: edgar/data/1070494/0001181431-07-074148-index.htm

2007-12-07 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc bought 2000 shares at $1.08 remaining shares owned 9864

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2007-12-07 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-074148.txt Sec File: edgar/data/1070494/0001181431-07-074148-index.htm

2007-12-06 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 2000 shares at $12.00 remaining shares owned 7864

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f1 these transactions were effected pursuant to a previously established sales plan under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for non-discretionary sales (and corresponding exercises of options, if applicable) pursuant to predetermined trading parameters that do not permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan.


Filed on 2007-12-07 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-074148.txt Sec File: edgar/data/1070494/0001181431-07-074148-index.htm

2007-12-06 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 2000 shares at $12.05 remaining shares owned 9864

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f1 these transactions were effected pursuant to a previously established sales plan under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for non-discretionary sales (and corresponding exercises of options, if applicable) pursuant to predetermined trading parameters that do not permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan.


Filed on 2007-12-07 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-074148.txt Sec File: edgar/data/1070494/0001181431-07-074148-index.htm

2007-12-06 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc bought 4000 shares at $1.08 remaining shares owned 11864

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security

f1 these transactions were effected pursuant to a previously established sales plan under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for non-discretionary sales (and corresponding exercises of options, if applicable) pursuant to predetermined trading parameters that do not permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan.
f2 includes 539 shares purchased on november 30, 2007 pursuant to the company's 2004 employee stock purchase plan.


Filed on 2007-12-07 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-074148.txt Sec File: edgar/data/1070494/0001181431-07-074148-index.htm

2007-12-06 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc remaining shares owned 2334

Common Stock Acadia Pharmaceuticals Inc Acad


Filed on 2007-11-16 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-070145.txt Sec File: edgar/data/1070494/0001181431-07-070145-index.htm

2007-11-15 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 5000 shares at $0 remaining shares owned 62990

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise date 2003-09-08 exercise price 1.08 has valueitem expiration due date 2013-09-07 underlying security shares 5000 underlying security title Common Stock


Filed on 2007-11-16 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-070145.txt Sec File: edgar/data/1070494/0001181431-07-070145-index.htm

2007-11-15 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc bought 5000 shares at $1.08 remaining shares owned 7325

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2007-11-16 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-070145.txt Sec File: edgar/data/1070494/0001181431-07-070145-index.htm

2007-11-14 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 2000 shares at $11.35 remaining shares owned 2334

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a previously established sales plan under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for non-discretionary sales pursuant to predetermined trading parameters that do not permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan.


Filed on 2007-11-16 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-070145.txt Sec File: edgar/data/1070494/0001181431-07-070145-index.htm

2007-11-14 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 100 shares at $11.24 remaining shares owned 4334

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a previously established sales plan under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for non-discretionary sales pursuant to predetermined trading parameters that do not permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan.


Filed on 2007-11-16 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-070145.txt Sec File: edgar/data/1070494/0001181431-07-070145-index.htm

2007-11-14 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 1900 shares at $11.23 remaining shares owned 4434

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a previously established sales plan under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for non-discretionary sales pursuant to predetermined trading parameters that do not permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan.


Filed on 2007-11-16 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-070145.txt Sec File: edgar/data/1070494/0001181431-07-070145-index.htm

2007-11-14 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 4000 shares at $11.05 remaining shares owned 6334

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f1 the sales reported in this form 4 were effected pursuant to a previously established sales plan under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for non-discretionary sales pursuant to predetermined trading parameters that do not permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan.


Filed on 2007-03-13 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-07-018930.txt Sec File: edgar/data/1070494/0001181431-07-018930-index.htm

2007-03-09 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc bought 22000 shares at $0 remaining shares owned 22000

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 6.86 has valueitem expiration due date 2017-03-08 underlying security shares 22000 underlying security title Common Stock

f1 25% of the shares subject to the stock option vest and become exercisable on march 9, 2008. the remaining shares vest and become exercisable thereafter in 36 equal monthly installments.


Filed on 2006-08-28 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-06-049945.txt Sec File: edgar/data/1070494/0001181431-06-049945-index.htm

2006-08-24 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 0 shares at $0 remaining shares owned 67990

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise date 2003-09-08 exercise price 1.08 has valueitem expiration due date 2013-09-07 underlying security shares 4000 underlying security title Common Stock


Filed on 2006-08-28 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-06-049945.txt Sec File: edgar/data/1070494/0001181431-06-049945-index.htm

2006-08-24 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 8000 shares at $8.00 remaining shares owned 12500

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: S Open market or private sale of securities

f3 the sale reported in this form 4 were made pursuant to an existing sales plan established during 2005 under rule 10b5-1 of the securities exchange act of 1934, as amended. the plan provides for the non-discretionary periodic sales of stock pursuant to predetermined trading parameters that do not permit mr. aasen to exercise any subsequent influence over how, when or whether to effect trades under the plan. future sales under the plan, in the aggregate, may not exceed a total of 8,000 shares over its remaining term.


Filed on 2006-08-28 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-06-049945.txt Sec File: edgar/data/1070494/0001181431-06-049945-index.htm

2006-08-24 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc bought 4000 shares at $0 remaining shares owned 20500

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2006-08-28 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-06-049945.txt Sec File: edgar/data/1070494/0001181431-06-049945-index.htm

2006-08-24 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 4000 shares at $0 remaining shares owned 14734

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses


Filed on 2006-08-28 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-06-049945.txt Sec File: edgar/data/1070494/0001181431-06-049945-index.htm

2006-08-24 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc bought 4000 shares at $0 remaining shares owned 18734

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: M Exercise or conversion of derivative security


Filed on 2006-08-28 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-06-049945.txt Sec File: edgar/data/1070494/0001181431-06-049945-index.htm

2006-06-05 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc sold 1000 shares at $0 remaining shares owned 14734

Common Stock Acadia Pharmaceuticals Inc Acad Transaction code: G Bona fide gift form of any clauses

f1 this disposition reflects a charitable gift made by the reporting person.
f2 includes an aggregate of 3,234 shares acquired by the reporting person pursuant to acadia's employee stock purchase plan from inception through the date of filing.


Filed on 2006-03-14 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001181431-06-017993.txt Sec File: edgar/data/1070494/0001181431-06-017993-index.htm

2006-03-10 Aasen Thomas H (CIK 1291969) through Direct (Vice Pres Cfo Treas Sec)

Invested in Acadia Pharmaceuticals Inc bought 25000 shares at $0 remaining shares owned 25000

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 14.83 has valueitem expiration due date 2016-03-09 underlying security shares 25000 underlying security title Common Stock

f1 25% of the shares subject to the stock option vest and become exercisable on march 10, 2007. the remaining shares vest and become exercisable thereafter in 36 equal monthly installments.


Filed on 2005-03-15 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 4

Accession 0001209191-05-015860.txt Sec File: edgar/data/1070494/0001209191-05-015860-index.htm

2005-03-11 Aasen Thomas H (CIK 1291969) through Direct (Vp Cfo Sec Treas)

Invested in Acadia Pharmaceuticals Inc bought 31000 shares at $0 remaining shares owned 31000

Stock Option Right To Buy Acadia Pharmaceuticals Inc Acad exercise price 6.95 has valueitem expiration due date 2015-03-10 underlying security shares 31000 underlying security title Common Stock

f1 25% of the shares subject to the stock option vest and become exercisable on march 11, 2006. the remaining shares vest and become exercisable thereafter in 36 equal monthly installments.


Filed on 2004-05-26 by Acadia Pharmaceuticals Inc SEC CIK 1070494 Form 3

Accession 0001179044-04-000092.txt Sec File: edgar/data/1070494/0001179044-04-000092-index.htm

2004-05-26 Aasen Thomas H (CIK 1291969) through Direct (Vice President And Cfo)

Invested in Acadia Pharmaceuticals Inc remaining shares owned 50000

Common Stock Acadia Pharmaceuticals Inc Acad